Merck & Co. Inc. buy Royal Bank of Canada
Start price
25.02.26
/
50%
€105.40
Target price
25.02.27
€120.47
Performance (%)
-6.58%
Price
12:53
€98.46
Summary
This prediction is currently active. With a performance of -6.58%, the BUY prediction for Merck & Co. Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 25.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | -6.542% | -6.542% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat